Due to these metabolic effects of GLP-1, it is primarily used in clinical practice to treat type 2 diabetes mellitus (T2DM) and obesity [1,2,3,4,5,6,7]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.